- /
- Supported exchanges
- / US
- / RVPH.NASDAQ
Reviva Pharmaceuticals Holdings Inc. (RVPH NASDAQ) stock market data APIs
Reviva Pharmaceuticals Holdings Inc. Financial Data Overview
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Reviva Pharmaceuticals Holdings Inc. data using free add-ons & libraries
Get Reviva Pharmaceuticals Holdings Inc. Fundamental Data
Reviva Pharmaceuticals Holdings Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -10 103 922
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Reviva Pharmaceuticals Holdings Inc. Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -0.29
Get Reviva Pharmaceuticals Holdings Inc. End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Reviva Pharmaceuticals Holdings Inc. News
New
RVPH: First Quarter 2026 Results
By John Vandermosten, CFA OTCQB: RVPH READ THE FULL RVPH RESEARCH REPORT Reviva Pharmaceutical Holdings, Inc. (OTCQB: RVPH) reported first quarter 2026 results following the announcement of the imp...
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Quantum Cyber (NASDAQ:QUCY) shares rose 163.0% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $4.0 million. Whitehawk Therapeutics (NASDAQ:WHW...
Dow Falls 200 Points; US Producer Prices Surge In April
U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.49% to 49,515.22 while the NAS...
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.